Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q3 2021 call → NOWe need answer YES/NO. Need analyze transcript. Need determine if management describes company currently living through defined waiting period paying out of pocket, benefit not arrived, end near-dated visible, working toward. Need one coherent situation. Let's parse transcript. Management discusses cost reset program, investments, capacity additions, price/cost headwinds, supply chain. Need identify if they describe currently paying for something not yet earning with specific near-dated event. Potential candidates: - Cost reset program: They are implementing restructuring actions, spending $600M, savings $650M by 2023. But benefits are already flowing, not waiting. They say cost reset benefits continued to be realized, savings flowing. So not waiting. - Capacity additions: Ram says adding capacity in U.S. and Mexico for Climate Technologies and tools. But not described as currently paying with no benefit yet? They mention construction in India, Mexico, Eastern Europe underway, some begin production later this year/early 2022. This could be a waiting period: investing in capacity before it operates. But is it main current work? Not really, and not quantified as cost landing. Also not specific near-dated? They mention begin production later this year/early 2022. But management doesn't frame as "paying now for something not yet earning" with cost in results. It's more investment. - Price/cost headwinds: They are absorbing material inflation, price cost negative $50M in quarter, expect max impact next two quarters, then pricing kicks in Jan. This is a cost burden currently landing, but it's imposed by commodity inflation, not self-funded waiting period. They are managing through, but not chosen price of arriving. End is pricing contracts opening Jan, but that's not a "benefit" from work in motion? It's market conditions. Also they say price/cost headwind is $75M, not something they are paying for future benefit. So no. - OSI acquisition: They say performing incredibly well, ahead of plan, not waiting. - New product investments: Copeland K7 scroll, Greenlee remote cutters, Gemini, Plantweb Optics. They are investing in technologies, but not described as currently paying with no benefit yet, no specific near-dated event. They mention "we will come out over next months and in depth in February" but not a defined waiting period.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.